Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Christensella: the key to unlocking gut microbiome-based drug discovery?

LNC Therapeutics recently signed an agreement with Cornell University for its Christensenella patent, a recently discovered family of gut bacteria considered to have the potential to unlock a wide range of applications for conditions such as obesity and other metabolic diseases. Will this form the foundation for the first drugs using microbiome bacteria?

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close

Go Top